Literature DB >> 8034207

Diabetes in primary open-angle glaucoma patients with inferior visual field defects.

J H Zeiter1, D H Shin.   

Abstract

We reviewed the charts of 144 randomly selected patients with primary open-angle glaucoma who had Aulhorn's stage 1, 2, or 3 visual field defects to investigate whether primary open-angle glaucoma patients with predominantly inferior visual field defects had a higher prevalence of diabetes mellitus than primary open-angle glaucoma patients without such visual field defects. Of the 59 patients with mainly inferior visual field defects in one or both eyes, 19 (32%) had diabetes mellitus, while 11 of 85 (13%) patients without such defects had diabetes mellitus. This difference was statistically significant (P = 0.0096). These results suggest that primary open-angle glaucoma patients with predominantly inferior visual field defects in one or both eyes are more likely to have diabetes and that such patients with no known history of diabetes may benefit from glucose tolerance testing to detect occult impaired glucose tolerance or diabetes mellitus.

Entities:  

Mesh:

Year:  1994        PMID: 8034207     DOI: 10.1007/bf00184006

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Reliability indexes of automated perimetric tests.

Authors:  J Katz; A Sommer
Journal:  Arch Ophthalmol       Date:  1988-09

2.  Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson Memorial Lecture.

Authors:  B Becker
Journal:  Am J Ophthalmol       Date:  1971-01       Impact factor: 5.258

3.  Diabetic retinopathy. Its relationship with intraocular pressure.

Authors:  I S Jain; C L Luthra
Journal:  Arch Ophthalmol       Date:  1967-08

4.  Optic nerve damage in glaucoma.

Authors:  D S Minckler; G L Spaeth
Journal:  Surv Ophthalmol       Date:  1981 Nov-Dec       Impact factor: 6.048

5.  The frequency distribution of earliest glaucomatous visual field defects documented by automatic perimetry.

Authors:  A Heijl; L Lundqvist
Journal:  Acta Ophthalmol (Copenh)       Date:  1984-08

6.  Visual field defects in diabetic patients with primary open-angle glaucoma.

Authors:  J H Zeiter; D H Shin; N H Baek
Journal:  Am J Ophthalmol       Date:  1991-05-15       Impact factor: 5.258

7.  Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham eye study.

Authors:  H A Kahn; R C Milton
Journal:  Arch Ophthalmol       Date:  1980-12

8.  The onset and evolution of glaucomatous visual field defects.

Authors:  W M Hart; B Becker
Journal:  Ophthalmology       Date:  1982-03       Impact factor: 12.079

9.  Prevalence of diabetes in glaucoma.

Authors:  R Mapstone; C V Clark
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

10.  Corneal power and astigmatism.

Authors:  I K Kragha
Journal:  Ann Ophthalmol       Date:  1986-01
View more
  5 in total

1.  Intraocular pressure and central visual field of normal tension glaucoma.

Authors:  M Araie; M Kitazawa; N Koseki
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

2.  Factors Related to Superior and Inferior Hemifield Defects in Primary Open-Angle Glaucoma.

Authors:  Remi Takeuchi; Nobuko Enomoto; Kyoko Ishida; Ayako Anraku; Goji Tomita
Journal:  J Ophthalmol       Date:  2019-04-14       Impact factor: 1.909

3.  Increased prelaminar tissue thickness in patients with open-angle glaucoma and type 2 diabetes.

Authors:  Yoon Seop Sim; Jin-Woo Kwon; Donghyun Jee; Jin A Choi; Seung-Hyun Ko; Chan Kee Park
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

4.  Glaucomatous vertical vessel density asymmetry of the temporal raphe detected with optical coherence tomography angiography.

Authors:  Yuji Yoshikawa; Takuhei Shoji; Junji Kanno; Hisashi Ibuki; Robert N Weinreb; Makoto Araie; Kei Shinoda
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

5.  The association of primary aldosteronism with glaucoma-related fundus abnormalities.

Authors:  Yoshimi Ohshima; Tomomi Higashide; Kimikazu Sakaguchi; Makoto Sasaki; Sachiko Udagawa; Shinji Ohkubo; Takashi Yoneda; Kazuhisa Sugiyama
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.